Background: Glycemic control in burn patients is critical for reducing infection and mortality. Objective: This study was conducted to assess the incidence and outcomes of hypoglycemia during continuous insulin infusions (CII). Methods: This institutional review board-approved study was a retrospective, single burn center, electronic chart review. Patients admitted between January 1, 2013, and October 31, 2014, who received a CII were included. Patients with incomplete data or who received <24 hours of CII were excluded. Results: Thirty-eight patients met inclusion criteria; 6 were excluded. The average patient was a 52-year-old Caucasian male with a 33% total body surface area burn and an acute physiology and chronic health evaluation (APACHE) II score of 20.Hypoglycemia was present for 87 of 6540 hours of CII therapy (1.1%). Two-thirds experienced a serum glucose <70 mg/dL and half <60 mg/dL. The most commonly assessed reasons for the hypoglycemic episodes were protocol violations (47%) and glucose variability (30%). After multivariable logistic regression, only history of diabetes remained a statistically significant risk factor with an odds ratio of 15.4 (95% confidence interval: 2.5-95.1). Four different CII protocols were prescribed. All protocols had a high glucose variability, as assessed by hours / day within goal range (13.1 ± 2.5, 14.1 ± 3.1, 14.3 ± 2.4, 9.8; P = .282). Conclusion: The amount of different protocols likely contributed to protocol violations and glucose variability. Our data demonstrate the need to create and consolidate usage to a single protocol in attempts to improve glycemic control.
Introduction
Adequate glycemic control is critical, yet difficult to achieve after thermal injury. Burn patients have altered processes, physiological responses, and increased resistance to insulin. 1, 2 Recommendations for blood glucose targets have changed over time for intensive care patients, and evidence exists to suggest benefit for a different target in thermal injury. Intensive insulin therapy, targeting blood glucoses between 81 and 108 mg/dL, was previously shown to improve morbidity and mortality. 3 However, subsequent studies have correlated intensive insulin therapy with a lower probability of survival due to more severe hypoglycemic (<40 mg/dL) events as compared with more conservative goals (<180 mg/dL). 4 The role of intensive insulin therapy may best serve select intensive care unit populations, such as cardiothoracic surgery, trauma, and burn. 1, [4] [5] [6] A target blood glucose less than 150 mg/dL in burn patients has been shown to achieve desired reductions in infection mortality balanced with a decreased incidence of hypoglycemia. 1, 5, 7 Additional evidence exists on the timing of attaining adequate glycemic control in burn patients with early control resulting in reductions in infectious complications and improved mortality. 5, 8 The purpose of this study is to assess and characterize the glycemic control of critically ill burn patients at our institution and to determine whether further action needs to be taken to better manage continuous insulin infusions (CII) in these patients. received a CII. Patients were excluded if they received the CII for less than 24 hours or had incomplete data in their electronic record. If multiple infusions were given during a single hospitalization, all infusions were included.
Data collected from the institutions electronic medical record included age, gender, race, weight, height, total body surface area (TBSA), length of stay (LOS), acute physiology and chronic health evaluation (APACHE) II score, survival, days of mechanical ventilation, type of burn injury, presence of infection, type of nutrition, average carbohydrate intake, hours of CII, point of care glucoses, average insulin received, hours in which blood glucose was less than 70, 60, and 40 mg/dL. The LOS was collected for the time in the intensive care unit and for total time hospitalized. Laboratory values collected included albumin, prealbumin, C-reactive protein, serum creatinine, creatinine clearance, hemoglobin A1c, white blood cell count, and blood glucose. All laboratory values were assessed at the start of the first CII. Renal function was assessed during the entirety of the CII, using the acute kidney injury network (AKIN) classification, to determine whether acute kidney injury or renal failure contributed to incidence of hypoglycemia.
Attributable cause of each hypoglycemic event was classified using 4 standard definitions: (1) a protocol violation that patient lacked concomitant tube feeds, total parenteral nutrition, or dextrose infusion during the CII; (2) renal failure; (3) glucose variability, defined as a change in blood glucose of greater than 50 mg/dL in 1 hour; or (4) other CII protocol violation. Hypoglycemic events that could not be explained by the any of the previous 4 explanations were classified as unknown.
SigmaPlot 11.2 was used for data analysis. Univariable analysis was used to compare patients with and without hypoglycemia. Independent variables with a P ≤ .1 were included in a multivariable logistic regression. During regression modeling, P < .05 was considered significant. Nominal data were analyzed by Fisher exact test. Continuous variables were compared using either Mann-Whitney U test or t test, depending on normal distribution. Shapiro-Wilk test was used to test for normal distribution. Analysis of variance was utilized to compare glucose variability between protocols.
Results
Thirty-eight patients were admitted to the burn center and started on CII between January 1, 2013, and October 31, 2014. Six patients were excluded for CII less than 24 hours (n = 5) and missing data in the electronic medical record (n = 1). The average patient was a 52-year-old Caucasian male, weighing 95 kg with a 33% TBSA burn with an APACHE II score of 20. Hypoglycemia was present in 87 of 6540 total hours of CII therapy (1.1%) or 2.7 hours per patient. Of the 32 included patients, two-thirds experienced at least 1 serum glucose less than 70 mg/dL and half less than 60 mg/dL. The most commonly assessed reasons for the hypoglycemic episodes were protocol violations (47%) and glucose variability (30%). Patients with hypoglycemia (<60 mg/dL) were older, had a history of diabetes, lower albumin and serum creatinine (Table 1) , longer CII duration and LOS, and lower average carbohydrate intake ( Table 2) . After multivariable logistic regression, only history of diabetes remained a statistically significant risk factor for hypoglycemia with an odds ratio of 15.4 (95% confidence interval: 2.5-95.1).
Overall, 4 different CII protocols were prescribed. During 37% of the hypoglycemic episodes, patients were receiving a modified CII usually reserved for patients with renal failure (Protocol 1). Forty-eight percent of episodes occurred when patients received a standard CII (Protocol 2), regardless of renal function. Protocol 1 reduced the amount of renal failure patients experiencing hypoglycemia from 91% to 62%. All of the protocols had a high glucose variability, as assessed by hours / day within goal range (13.1 ± 2.5, 14.1 ± 3.1, 14.3 ± 2.4, 9.8; P = .282) (Figure 1 ). Protocols 0 and 3 had lower rates of hypoglycemia, but also lower time within the goal range.
Discussion
In this study, the authors investigated patients receiving CII to determine incidence of hypoglycemia. The authors attempted to define each episode with an ultimate goal of future improvement. During the study period, 50% of included patients had an episode of clinically significant hypoglycemia (<60 mg/dL). The amount of patients experiencing hypoglycemia is concerning due to the association of hypoglycemia with morbidity and mortality in critically ill patients. 4 The high incidence of hypoglycemia was associated with longer LOS and longer time on CII. It is difficult to determine whether the extended stay was due to hypoglycemic episodes or the underlying severity of the burn injury. The study was not powered to perform regression analysis on predictors of increased LOS and the study was retrospective, thus causality cannot be determined. Factoring in the highly dynamic nature of patients with burn injury, increased insulin resistance, a past medical history of diabetes and obesity, and incidence of renal failure, glycemic control becomes difficult to achieve on a consistent basis. There was nearly 3 times the number of patients with a history of diabetes in the group that experienced hypoglycemic events. Patients with a history of diabetes have also been shown to sustain a higher percentage of full thickness burns, operations, infections, and longer LOS over nondiabetics. 9 The purpose of this study was not to analyze effects on LOS, but identify areas to potentially reduce glucose variability and improve glycemic control Renal function plays an important role in the regulation of insulin in the body. Approximately 50% of systemic insulin is cleared through the kidneys. 10 The modified protocol used in this study is less aggressive and generally reserved for renal failure. The modified protocol decreased the incidence of hypoglycemia in renal failure patients from 91% to 62%. Although the incidence did decrease, the rate of hypoglycemia in this study's renal failure patients is still unacceptable. At the time of this study, 4 different CII protocols were approved at the authors' institution. During the study period, all 4 were utilized in the patient sample. The protocols varied with respect to goal range, how to titrate and wean, and even hypoglycemia definitions and treatment. The amount of available protocols can be attributed to different prescribing practices among physicians and complications implementing a new electronic medical record. The excessive number of protocols could have possibly attributed to the amount of glucose variability and protocol violations. It is likely that staff education could provide improvement in glycemic control and reduce protocol violations for the future. Even if reduced, violations will likely still occur and only accounted for about half of our explained events. Perhaps limiting the amount of protocols prescribed and standardizing a hypoglycemic protocol will prevent confusion on goals and enhance glycemic control. Further, none of the 4 protocols achieved acceptable control as evidenced by time within goal range. Glucose variability accounted for nearly one-third of the hypoglycemic events. During data analysis, the authors observed large decreases in glucoses occurred immediately prior to many of the variability-associated events, which all 4 protocols fail to address. The authors believe not only consolidating to one protocol is necessary, but perhaps a new protocol be established that incorporates the change in glucose.
This study has several limitations. This study was not powered to detect differences in outcomes in patients incurring hypoglycemic events; however, clinical outcomes were not the focus of this study. Subjectivity and investigator bias could have played a role in assigning definitive cause for each episode. In best efforts to avoid bias, 2 separate authors independently assessed each event. The hypoglycemic group had a larger portion of patients with a history of diabetes. Because these patients have underlying issues regulating insulin and glucose, they may be more susceptible to variability in glucose levels. The blood glucose levels were measured using point of care bedside testing. Bedside glucose testing has been shown to result in falsely elevated blood glucose levels in critically ill patients in the intensive care unit. 11 Thus, some incidences of hypoglycemia may have been missed. No patient was receiving any other agent other than insulin to assist in glycemic control. Future efforts may be aided by use of additional agents to reduce insulin resistance and gluconeogenesis, specifically metformin. 12 The overall rates of hypoglycemia, blood glucose variability, and protocol violations raise concerns about the protocols in use during the time period of the study. Education to increase protocol adherence is unlikely to achieve adequate control, as evidenced by the high percentage of patients with large drops in glucose in absence of protocol violations. The amount of different protocols in use likely contributed to protocol violations. Our data together with nursing feedback and updated glucose targets demonstrate the need to create and consolidate usage to a single protocol in attempts to improve glycemic control.
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